Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELE | P16581 | 16/20 | 0.88 |
| ▸ | SELP | P16109 | 3/20 | 0.37 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17903034 | 1.00 | SELE (0.88) | SELESELPAMY1A | |
| SCHEMBL13272239 | 1.00 | SELE (0.88) | SELESELPAMY1A | |
| SCHEMBL18211304 | 1.00 | SELE (0.88) | SELESELPAMY1A | |
| SCHEMBL12903105 | 0.96 | SELE (0.81) | SELESELP | |
| SCHEMBL12903106 | 0.91 | SELE (0.74) | SELESELP | |
| SCHEMBL17903035 | 0.90 | SELE (1.00) | SELESELPAMY1A | |
| SCHEMBL12903109 | 0.90 | SELE (0.73) | SELE | |
| SCHEMBL12903231 | 0.90 | SELE (0.73) | SELEAMY1A | |
| SCHEMBL14214814 | 0.90 | SELE (0.71) | SELESELP | |
| SCHEMBL13272246 | 0.89 | SELE (0.70) | SELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8258290-B2 | Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from pseudomonas | GLYCOMIMETICS, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| EP-1928892-B1 | GLYCOMIMETIC INHIBITORS OF THE PA-IL LECTIN, PA-IIL LECTIN OR BOTH THE LECTINS FROM PSEUDOMONAS | GLYCOMIMETICS INC (US) | 2011-10-12 | — | — | EP | disclosed |
| US-20100041626-A1 | GLYCOMIMETIC INHIBITORS OF THE PA-IL LECTIN, PA-IIL LECTIN OR BOTH THE LECTINS FROM PSEUDOMONAS | GLYCOMIMETICS, INC. (US) | 2010-02-18 | — | — | US | disclosed |
| US-7517980-B2 | Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from Pseudomonas | GLYCOMIMETICS, INC. (US) | 2009-04-14 | — | — | US | disclosed |
| US-20070037775-A1 | drugs having a high receptivity for hemagglutinins, used for diagnosis and therapy of bacterial infections | GLYCOMIMETICS, INC. (US) | 2007-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041626-A1 | GLYCOMIMETIC INHIBITORS OF THE PA-IL LECTIN, PA-IIL LECTIN OR BOTH THE LECTINS FROM PSEUDOMONAS | MASP2, SERPINB1, SIGLEC7 | SELE 819/4885SELP 132/4885AMY1A 1398/4885 |
| US-20070037775-A1 | drugs having a high receptivity for hemagglutinins, used for diagnosis and therapy of bacterial infections | CFTR, CD44, HDGF | SELE 340/4885SELP 310/4885AMY1A 4500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.